The Effect of Ocrelizumab on Anti-JC Virus Antibody Index, B Cells and Immunoglobulins: a Longitudinal Study

被引：0
|
作者：
Virupakshaiah, A. [1 ]
Gill, A. [2 ]
Schoeps, V. A. [1 ]
Wilson, E. [3 ]
Wilson, J. [3 ]
Jacobs, D. [4 ]
Do, D. [3 ]
Berger, J. R. [4 ]
机构：
[1] UCSF, Neurol, San Francisco, CA USA
[2] Johns Hopkins Med, Neurol, Baltimore, MD USA
[3] Penn Med, Neurol, Philadelphia, PA USA
[4] Univ Penn, Neurol, Philadelphia, PA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P173
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [21] Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report
    Miranda Acuna, Jahir Andres
    Weinstock-Guttman, Bianca
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 54 - 55
  • [22] Rate of sero-conversion of anti-JC virus antibody among multiple sclerosis patients in Kuwait
    Alroughani, R.
    Ahmed, S.
    Shaalan, N.
    Al-Sherbiny, D.
    Al-Hashel, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E295 - E296
  • [23] Anti-JC virus antibody prevalence in a Finnish cohort of patients with multiple sclerosis and clinically isolated syndrome
    Kolasa, M.
    Hagman, S.
    Verkkoniemi-Ahola, A.
    Airas, L.
    Koivisto, K.
    Elovaara, I.
    JOURNAL OF NEUROLOGY, 2014, 261 : S95 - S95
  • [24] Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence
    Koolaji, Sogol
    Allahabadi, Narges Sistany
    Ahmadi, Arash
    Eskandarieh, Sharareh
    Moghadasi, Abdorreza Naser
    Azimi, Amir Reza
    Sahraian, Mohammad Ali
    JOURNAL OF NEUROVIROLOGY, 2018, 24 (05) : 570 - 576
  • [25] Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence
    Sogol Koolaji
    Narges Sistany Allahabadi
    Arash Ahmadi
    Sharareh Eskandarieh
    Abdorreza Naser Moghadasi
    Amir Reza Azimi
    Mohammad Ali Sahraian
    Journal of NeuroVirology, 2018, 24 : 570 - 576
  • [26] Development of Anti-JC Virus "Designer T Cells" for Progressive Multifocal Leukoencephalopathy (PML) Immunotherapy
    Yang, Wen
    Beaudoin, Esther
    Du Pasquier, Renaud A.
    Koralnik, Igor J.
    Junghans, Richard P.
    MOLECULAR THERAPY, 2006, 13 : S228 - S229
  • [27] Prevalence of Anti-JC Virus Antibody Seropositivity in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Hanaei, Sara
    Sahraian, Mohammad Ali
    Mohammadifar, Mehdi
    Ramagopalan, Sreeram, V
    Ghajarzadeh, Mahyar
    Ghajarzadeh, Mahsa
    INTERVIROLOGY, 2020, 62 (5-6) : 169 - 173
  • [28] Clinical Utility of Anti-JC Virus Antibody Testing in Crohn's Disease: Rate of Seropositivity and Impact on Therapy With Natalizumab
    Hwang, Caroline
    Fisher, Elena R.
    Terdiman, Jonathan P.
    Mahadevan, Uma
    Velayos, Fernando S.
    GASTROENTEROLOGY, 2012, 142 (05) : S64 - S64
  • [29] Prevalence of Anti-JC Virus (JCV) Antibodies in the Multiple Sclerosis (MS) Population in Cyprus: A Retrospective Study
    Lambrianides, Sakis
    Demetriou, Christiana A.
    Tillyris, Andis
    Kkolou, Elena
    Gaglia, Eftychia
    Agkastinioti, Eleni
    Leonidou, Eleni
    Christou, Yiolanda-Panayiota
    Papacostas, Savvas S.
    Kleopa, Kleopas A.
    Kyriakides, Theodoros
    Pantzaris, Marios
    NEUROLOGY RESEARCH INTERNATIONAL, 2019, 2019
  • [30] Development of anti-JC virus-designer T cells-for progressive multifocal leukoencephalopathy (PML) immunotherapy
    Yang, Wen
    Du Pasquier, Renaud A.
    Beaudoin, Esther
    Koralnik, Igor J.
    Junghans, Richard P.
    JOURNAL OF NEUROVIROLOGY, 2005, 14 : 124 - 124
12345